World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma AB informs about presentations where the company participates on February 19
Read more >> -
Xbrane Biopharma AB informs about presentations where the company participates on February 19
Read more >> -
Martin Åmark, VD för Xbrane Biopharma AB, blir även IR-ansvarig i bolaget
Read more >> -
Martin Åmark, CEO for Xbrane Biopharma AB, becomes Head of IR for the Company
Read more >> -
Xbrane Biopharma tillkännager godkännande för initiering av klinisk studie med Xlucane i USA
Read more >>
X
